Program Antibody definition

Program Antibody means the optimized and humanized compositions of matter developed under the Program, and the cDNA encoding such compositions of matter, delivered to Bio-Management hereunder.
Program Antibody means each antibody that has the same sequence of any antibody generated from use of the Adimab Platform Technology and delivered by Adimab to iTeos under a Research Program. It is understood and agreed that even if Adimab delivers nucleic acid sequences or amino acid sequences to iTeos instead of protein samples, antibodies encoded by such nucleic acid sequences or amino acid sequences are Program Antibodies, in addition to antibodies samples of which are physically delivered to iTeos under this Agreement.
Program Antibody means any [*****] created, discovered, conceived or reduced to practice by the Parties jointly or solely by either Party during the conduct of activities under the Research Program or Research Plan during the Research Term.

Examples of Program Antibody in a sentence

  • If Surface or its Affiliates challenges in a court the validity, enforceability or scope of any Adimab Platform Patents or any Program Antibody Patent, then: [***].

  • Surface shall be responsible, at its sole expense, to Prosecute all Program Patents directed to Surface Program Inventions but not falling within Program Antibody Patents or the Adimab Platform Technology Improvements (which, to avoid doubt, are both addressed above).

  • After Commercial Option exercise, if elections with respect to obtaining such patent term restoration are to be made with respect to Licensed Program Antibody Patents, and the Parties do not agree, Surface shall have the right to make the election and Xxxxxx agrees to abide by such election.

  • Adimab shall solely own, regardless of inventorship, all Patents Covering Adimab Platform Technology Improvements and, prior to Commercial Option exercise, all Program Antibody Patents.

  • During the term of the Agreement, each Party shall promptly disclose to the other Party [***] any Program Inventions that would be Covered by Program Antibody Patents or in Surface’s case that are Adimab Platform Technology Improvements (which, to avoid doubt, are assigned to Adimab under this Agreement).


More Definitions of Program Antibody

Program Antibody means any Tau-Active Antibody created, discovered, conceived or reduced to practice by the Parties jointly or solely by either Party during the conduct of activities under the Research Program or Research Plan during the Research Term.
Program Antibody means any PD-L1 Antibody. It is understood and agreed that even if Adimab delivers nucleic acid sequences or amino acid sequences to Checkpoint instead of protein samples, antibodies encoded by such nucleic acid sequences or amino acid sequences are Program Antibodies, in addition to antibodies samples of which are physically delivered to Checkpoint under this Agreement.
Program Antibody means a [*****] that [*****] and that Genmab has elected to use in a Program and which has been finally cleared under Section 3.2.2. To the extent applicable, and unless otherwise set forth, [*****].
Program Antibody means, with respect to each Target, each antibody [***] under a Research Program for such Target. It is understood and agreed that [***].
Program Antibody means, on a Program-by-Program basis, [***].
Program Antibody means any and all antibodies (or similar molecule), including Fc, Fv or Fab components or fragments or analogues thereof, derived and generated from a [...***...] (or either [...***...] included therein) through the application of the Zymeworks Platform pursuant to the Research Program. 21
Program Antibody means an antibody that (a) is first conceived or synthesized, or the variable regions of which have been modified, by Ixsys, Xxxxxxx-Xxxxx or both during and pursuant to the Research Program; and (b) is specifically reactive immunologically with solid tumor antigens; whether or not the variable regions of such antibody have been modified by Xxxxxxx-Xxxxx, its Affiliates or permitted sublicensees after termination of the Research Program.